All Stories

  1. A Screening Pattern Recognition Method Finds New and Divergent Targets for Drugs and Natural Products
  2. Predictive ADMET
  3. Current Social, Clinical, and Scientific Environment of Pharmaceutical R&D
  4. Translation of off-target effects: prediction of ADRs by integrated experimental and computational approach
  5. Hazard identification and elimination: designing safe medicines
  6. Large-scale prediction and testing of drug activity on side-effect targets
  7. Screening for Safety-Relevant Off-Target Activities
  8. Using Full Factorial Design of Experiments on an Automated Patch Clamp Instrument: A Case Study on the Ionworks Quattro and Nav1.5 Channel
  9. IonFlux: A Microfluidic Patch Clamp System Evaluated with Human Ether-à-go-go Related Gene Channel Physiology and Pharmacology
  10. Cardiac ion channel safety profiling on the IonWorks Quattro system
  11. Mechanisms of hERG Potassium Channel Enhancers
  12. TRPV1 Function in Health and Disease
  13. Molecular Structure of Transient Receptor Potential Vanilloid Type 1 Ion Channel (TRPV1)
  14. Cardiac Ion Channel Safety Profiling on the IonWorks Quattro Automated Patch Clamp System
  15. Phenotypic screening: Fishing for neuroactive compounds
  16. Role of Transient Receptor Potential and Acid-sensing Ion Channels in Peripheral Inflammatory Pain
  17. Hit and Lead Profiling
  18. Integrative Risk Assessment
  19. SPREAD-exploiting chemical features that cause differential activity behavior
  20. In vitrosafety pharmacology profiling: what else beyond hERG?
  21. Mapping Adverse Drug Reactions in Chemical Space
  22. Gaining Insight into Off-Target Mediated Effects of Drug Candidates with a Comprehensive Systems Chemical Biology Analysis
  23. Predictive Toxicology in Drug Safety
  24. Functional Molecular Biology of the TRPV1 Ion Channel
  25. Maximising use ofin vitroADMET tools to predictin vivobioavailability and safety
  26. Modeling Promiscuity Based on in vitro Safety Pharmacology Profiling Data
  27. Analysis of Pharmacology Data and the Prediction of Adverse Drug Reactions and Off-Target Effects from Chemical Structure
  28. Cover Picture: Analysis of Pharmacology Data and the Prediction of Adverse Drug Reactions and Off-Target Effects from Chemical Structure (ChemMedChem 6/2007)
  29. High-throughputinvitroprofiling assays: lessons learnt from experiences at Novartis
  30. Mechanisms underlying joint pain
  31. Keynote review: In vitro safety pharmacology profiling: an essential tool for successful drug development
  32. Preclinical pharmacology of lumiracoxib: a novel selective inhibitor of cyclooxygenase-2
  33. The role of the vanilloid (capsaicin) receptor (TRPV1) in physiology and pathology
  34. Anti-hyperalgesic activity of the cox-2 inhibitor lumiracoxib in a model of bone cancer pain in the rat
  35. Anandamide regulates neuropeptide release from capsaicin-sensitive primary sensory neurons by activating both the cannabinoid 1 receptor and the vanilloid receptor 1in vitro
  36. THIS ARTICLE HAS BEEN RETRACTED Activation of capsaicin-sensitive primary sensory neurones induces anandamide production and release
  37. Disease modifying and anti-nociceptive effects of the bisphosphonate, zoledronic acid in a model of bone cancer pain
  38. Spinal Neurokinin NK1 Receptor Down-Regulation and Antinociception: Effects of Spinal NK1 Receptor Antisense Oligonucleotides and NK1 Receptor Occupancy
  39. The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain. (Novartic Institute for Medical Sciences, London, United Kingdom) Pain. 2001;92:91-100.
  40. Possible mechanisms of cannabinoid-induced antinociception in the spinal cord
  41. The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain
  42. The neurogenic contribution to synovial leucocyte infiltration and other outcome measures in a guinea pig model of arthritis
  43. The effects of GABAB agonists and gabapentin on mechanical hyperalgesia in models of neuropathic and inflammatory pain in the rat
  44. “Neuropeptides 2000”
  45. Differential role of neurokinin receptors in human lymphocyte and monocyte chemotaxis
  46. Excitatory effects of galanin in the spinal cord of intact, anaesthetized rats
  47. In vivo pharmacology of SDZ 249-665, a novel, non-pungent capsaicin analogue
  48. Intrathecally administered endotoxin or cytokines produce allodynia, hyperalgesia and changes in spinal cord neuronal responses to nociceptive stimuli in the rat
  49. Oral anti-hyperalgesic and anti-inflammatory activity of NK1 receptor antagonists in models of inflammatory hyperalgesia of the guinea-pig
  50. Repeated administration of systemic gabapentin alleviates allodynia-like behaviors in spinally injured rats
  51. Animal models for pain research
  52. Critical evaluation of the streptozotocin model of painful diabetic neuropathy in the rat
  53. Pharmacology of Chronic Pain
  54. Immunohistochemical localization of neurokinin-1 receptor in the lumbar spinal cord of young rats: morphology and distribution
  55. Distribution and developmental changes in metabotropic glutamate receptor messenger RNA expression in the rat lumbar spinal cord
  56. The effects of SDZ NKT 343, a potent NK1 receptor antagonist, on cutaneous responses of primate spinothalamic tract neurones sensitized by intradermal capsaicin injection
  57. mGluR activation reveals a tonic NMDA component in inflammatory hyperalgesia
  58. Alterations of substance P immunoreactivity in lumbar and thoracic segments of rat spinal cord in ultraviolet irradiation induced hyperalgesia of the hindpaw
  59. Sympathetic component of neuropathic pain: Animal models and clinical diagnosis
  60. Is there a nociceptive carousel?
  61. Bradykinin depolarises the rat isolated superior cervical ganglion via B2 receptor activation
  62. Pharmacology of chronic pain
  63. Tachykinin induced regulation of excitatory amino acid responses in the rat spinal cord in vitro
  64. Cellular Mechanisms of Sensory Processing
  65. Hyperexcitabilty in the Spinal Dorsal Horn: Cooperation of Neuropeptides and Excitatory Amino Acids
  66. The effects of NK-1 and NK-2 receptor antagonists on the capsaicin evoked synaptic response in the rat spinal cord in vitro
  67. Correlation Between Function and Structure in "Epileptic" Human Hippocampal Tissue Maintained In Vitro
  68. Effect of capsaicin and resiniferatoxin on peptidergic neurons in cultured dorsal root ganglion
  69. Capsazepine, a novel capsaicin antagonist, selectively antagonises the effects of capsaicin in the mouse spinal cord in vitro
  70. The responses recorded in vitro of deep dorsal horn neurons to direct and orthodromic stimulation in the young rat spinal cord
  71. Prologue – Predictive toxicology: a new chapter in drug safety evaluation
  72. Integrated approaches to lead optimization: improving the therapeutic index
  73. PREDICTIVE TOXICOLOGY IN DRUG SAFETY